Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.
Treats Attention Deficit Hyperactivity Disorders (ADHD) and Narcolepsy. Sold as Ritalin, Ritalin-Sr, Concerta, Metadate Cd, Ritalin La and 7 more. Every FDA application for this active ingredient: 13 branded and 73 generic.
As of Nov 15, 2026, FDA lists 86 applications for Methylphenidate Hydrochloride (sold as Ritalin, Ritalin-Sr, Concerta and others), first approved Dec 5, 1955, with 5 new uses approved and 1 published complete response letter.
First approved: Dec 5, 1955
Applications: 86
New uses approved: 5
Complete response letters: 1
Medicare spending, 2025: $54.5M
First approved in the EU: Feb 28, 2025
Shortage: Current
Medicare Spending
CMS Part D and Part B, 2025, before manufacturer rebates; matched by generic name
Methylphenidate ER
Part D
$19.1M
-4%
41,330
Methylphenidate HCl
Part D
$18.2M
+21%
108,493
Concerta
Part D
$8.3M
-21%
2,718
Methylphenidate ER (La)
Part D
$4.0M
+23%
5,810
Jornay PM
Part D
$2.0M
+39%
713
Methylphenidate HCl ER (Cd)
Part D
$1.3M
-3%
3,193
Ritalin
Part D
$592K
-18%
797
Quillichew ER
Part D
$289K
+2%
117
Quillivant XR
Part D
$217K
+15%
71
Methylphenidate HCl CD
Part D
$187K
-74%
1,044
Ritalin La
Part D
$167K
-76%
130
Relexxii
Part D
$51K
+30%
36
Metadate CD
Part D
$48K
New
32
Aptensio XR
Part D
$13K
-72%
21
Methylin
Part D
$0K
-100%
0
What Pharmacies Pay
Median price per unit across package codes in CMS's weekly NADAC survey, Nov 11, 2026, before rebates; see every drug's price change
METHYLPHENIDATE 10 MG CHEW TAB: $2.90 per unitGeneric · -2% in a year
METHYLPHENIDATE 10 MG TABLET: $0.150 per unitGeneric · -19% in a year
METHYLPHENIDATE 10 MG/5 ML SOL: $0.116 per MLGeneric · -2% in a year
METHYLPHENIDATE 10 MG/9 HR PATCH: $6.30 per unitGeneric · -32% in a year
METHYLPHENIDATE 15 MG/9 HR PATCH: $6.27 per unitGeneric · -35% in a year
METHYLPHENIDATE 2.5 MG CHEW TB: $1.31 per unitGeneric · +18% in a year
METHYLPHENIDATE 20 MG TABLET: $0.199 per unitGeneric · -11% in a year
METHYLPHENIDATE 20 MG/9 HR PATCH: $6.16 per unitGeneric · -42% in a year
METHYLPHENIDATE 30 MG/9 HR PATCH: $6.61 per unitGeneric · -30% in a year
METHYLPHENIDATE 5 MG CHEW TAB: $1.99 per unitGeneric · +5% in a year
METHYLPHENIDATE 5 MG TABLET: $0.122 per unitGeneric · -11% in a year
METHYLPHENIDATE 5 MG/5 ML SOLN: $0.079 per MLGeneric · +2% in a year
Concerta, new approvalA drug with a new indication and a new dosage in an additional dosage form indicated for the treatment of attention deficit/hyperactivity disorder (AD/HD)… · Janssen Pharmaceutical K.K. · Jan 17, 2014
ConcertaDrugs with a new additional indication and a new dosage for the treatment of attention- deficit/hyperactivity disorder (AD/HD) in adults. · Janssen Pharmaceutical K.K. · Dec 20, 2013
Applications, approvals and products come from FDA's Drugs@FDA data files, refreshed weekly, grouped by active ingredient as FDA spells it. Complete response letters are FDA's published letters. Medicare spending is CMS's Part D and Part B dashboard, matched to this ingredient by generic name; shortages are FDA's shortage list, matched by application number; clinical trials are ClinicalTrials.gov studies naming the ingredient as an intervention, refreshed daily; safety programs are FDA's REMS list, matched by application number or, for shared programs, by ingredient.Drugs@FDA